Hümmert, M. W., Schöppe, L. M., Bellmann-Strobl, J., Siebert, N., Paul, F., Duchow, A., Pellkofer, H., Kümpfel, T., Havla, J., Jarius, S., Wildemann, B., Berthele, A., Bergh, F. T., Pawlitzki, M., Klotz, L., Kleiter, I., Stangel, M., Gingele, S., Weber, M. S., Faiss, J. H., Pul, R., Walter, A., Zettl, U. K., Senel, M., Stellmann, J., Häußler, V., Hellwig, K., Ayzenberg, I., Aktas, O., Ringelstein, M., Schreiber-Katz, O., & Trebst, C. (2022). costs and Health-Related Quality of Life in Patients With NMO Spectrum Disorders and MOG-Antibody–Associated Disease. Neurology, 98, . http://access.bl.uk/ark:/81055/vdc_100182975856.0x00002d